Tolerance induction ameliorates allograft vasculopathy in rat aortic transplants: Influence of Fas-mediated apoptosis

Journal of Clinical Investigation

Volumn 101, Issue 12, 1998, Pages 2889-2899

  Akyürek, Levent M ^a,c   Johnsson, Cecilia ^a   Lange, Dirk ^b   Georgii Hemming, Patrik ^a   Larsson, Erik ^a   Fellström, Bengt C ^a   Funa, Keiko ^b,d   Tufveson, Gunnar ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Arteriosclerosis; Chronic rejection; Cyclosporine; Fas; Ischemia

Indexed keywords

CYCLOSPORIN; FAS ANTIGEN; FAS LIGAND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; AORTA GRAFT; APOPTOSIS; ARTERIOSCLEROSIS; ARTICLE; COLD INJURY; CONTROLLED STUDY; GRAFT REJECTION; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; INTIMA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR DISEASE;

EID: 0345616655     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI1177     Document Type: Article

References (53)

1. Fellström, B.C., and E. Larsson. 1993. Pathogenesis and treatment perspectives of chronic graft rejection (CVR). Immunol. Rev. 134:83-98.
2. Wanders, A., M.L. Akyürek, J. Waltenberger, Z.P. Ren, C. Stafberg, K. Funa, E. Larsson, and B. Fellström. 1995. Ischemia-induced transplant arteriosclerosis in the rat. Arterioscler. Thromb. Vasc. Biol. 15:145-155.
3. Orloff, M.S., E.M. DeMara, M.L. Coppage, N. Leong, M.A. Fallon, J. Sickel, X.J. Zuo, J. Prehn, and S.C. Jordan. 1995. Prevention of chronic rejection and graft arteriosclerosis by tolerance induction. Transplantation. 59:282-288.
4. Blom, D., N.J. Morrissey, C. Mesonero, M. Coppage, T. Fisher, X.J. Zuo, S.C. Jordan, and M.S. Orloff. 1996. Induction of specific tolerance through mixed hematopoietic chimerism prevents chronic renal allograft rejection in a rat model. Surgery. 120:219-220.
5. Claesson, K., P. Larsson, R. Holmdahl, L. Klareskog, U. Forsum, and G. Tufveson. 1987. Positive effects of anti-T-cell monoclonal antibodies on rat allograft. Transplant. Proc. 19:615-616.
6. Shirwan, H., H.K. Wang, L. Barwari, L. Makowka, and D.V. Cramer. 1996. Pretransplant injection of allograft recipients with donor blood or lymphocytes permits allograft tolerance without the presence of persistent donor microchimerism. Transplantation. 61:1382-1386.
7. Räisenen-Sokolowski, A., S. Yilmaz, T. Paavonen, M.J. Tikkanen, and P. Häyry. 1994. Partial inhibiton of allograft arteriosclerosis (chronic rejection) by 15-deoxyspergualin. Transplantation. 57:1772-1777.
8. Hewith, C.W., K.S. Black, J.C. Harman, K.R. Beko II, H.S. Lee, A.P. Patel, and D.C. Martin. 1990. Partial tolerance in rat renal allograft recipients following multiple blood transfusions and concomitant cyclosporine. Transplantation. 49:194-198.
9. Stein-Oakley, A.N., P. Jablonski, A. Tzanidis, K. Baxter, B.O. Howden, V.C. Marshall, and N.M. Thomson. 1993. Development of chronic injury and nature of interstitial infiltrate in a model of chronic renal allograft rejection. Transplantation. 56:1299-1305.
10. Zhang, H., L. Horwitz, P. Ruvolo, P. Colombani, and A.D. Hess. 1995. The role of cyclosporine-induced autoreactive T lymphocytes in solid organ allograft survival and chronic rejection. Transplantation. 60:115-122.
11. Jablonski, P., K. Baxter, B.O. Howden, A.C. Thomas, V.C. Marshall, A. Stein-Oakley, and N.M. Thomson. 1995. A reproducible model of chronic rejection in rat renal allografts. Aust. NZ. J. Surg. 65:114-119.
12. Sayegh, M.H., and C.B. Carpenter. 1996. Role of indirect allorecognition in allograft rejection. Int. Rev. Immunol. 13:221-229.
13. Akyürek, M.L. 1996. Transplant arteriosclerosis. Experimental studies in the rat. Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine. Acta Universitatis Upsaliensis. 654:24-27.
14. Dong, C., J.E. Wilson, G.L. Winters, and B.M. McManus. 1996. Human transplant coronary artery disease: pathological evidence for Fas-mediated apoptotic cytotoxicity in allograft vasculopathy. Lab. Invest. 74:921-931.
15. Suda, T., and S. Nagata. 1994. Purification and characterization of the Fas-ligand that induces apoptosis. J. Exp. Med. 179:873-879.
16. Laine, J., P. Etelämäki, C. Holmberg, and L. Dunkel. 1997. Apoptotic cell death in human chronic renal allograft rejection. Transplantation. 63:101-105.
17. Bergese, S.D., S.M. Klenotic, M.E. Wakely, D.D. Sedmak, and C.G. Orosz. 1997. Apoptosis in murine cardiac grafts. Transplantation. 63:320-325.
18. Gavrieli, Y., Y. Sherman, and S.A. Ben-Sasson. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493-501.
19. Johnsson, C., and G. Tufveson. 1994. MC 1288 - a vitamin D analogue with immunosuppressive effects on heart and small bowel grafts. Transplant. Int. 7:392-397.
20. Olausson, M., L. Mjörnstedt, L. Lindholm, and H. Brynger. 1984. Nonsuture organ grafting to the neck vessels in the rat. Acta Chir. Scand. 150:463-467.
21. Jacobsson, J., J. Wahlberg, L. Frödin, B. Odlin, and G. Tufveson. 1989. Organ flush out solutions and cold storage preservation solutions: effect on organ cooling and post-ischemic erythrocyte trapping in kidney grafts. Scand. J. Urol. Nephrol. 32:219-222.
22. Institute of Laboratory Animal Resources. Committee on Care and Use of Laboratory Animals. 1985. Guide for the Care and Use of Laboratory Animals. U.S. Department of Health, Public Health Service, National Institutes of Health. Bethesda, MD. 86-123.
23. DeLellis, R.L., and M.C. Bowling. 1970. The use of Sirius red and Congo red staining in routine histopathology. Hum. Pathol. 1:655.
24. Drappa, J., N. Brot. and K.B. Elkon. 1993. The Fas protein is expressed at high levels on CD4+CD8+ thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain. MRL 1pr/1pr. Proc. Natl. Acad. Sci. USA. 90:10340-10344.
25. Suda, T., T. Takahashi, P. Golstein, and S. Nagata. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell. 75:1169-1178.
26. Waseem, N.H., and D.P. Lane. 1990. Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form. J. Cell. Sci. 96:121-129.
27. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol chloroform extraction. Anal. Biochem. 162:156-160.
28. Yoshimura, N., and B.H. Kahan. 1985. Induction of T suppressor cells by extracted histocompalibilty antigen combined with cyclosporine. Transplant. Proc. 17:1341.
29. Ito, T., S. Stepkowski, and B.D. Kahan. 1988. Frequency of T cytotoxic cells after perioperative treatment with extracted antigen and cyclosporine in rat cardiac transplantation. Transplant. Proc. 20:1045-1052.
30. Posselt, A.M., C.F. Barker, J.E. Tomaszewski, J.F. Markmann, M.A. Choti, and A. Naji. 1990. Induction of donor-specific unresponsiveness by intrathymic islet. Science. 249:1293-1295.
31. Remuzzi, G., and N. Perico. 1991. Induction of unresponsiveness via intrathymic inoculation. Lancet. 338:1487-1488.
32. Chowdhury, N.C., R.A. Fawwaz, and S.F. Oluwole. 1993. Induction of donor-specific tolerance to rat cardiac and small bowel. J. Surg. Res. 54:368-374.
33. Fellström, B.C., M.L. Akyürek, E.M. Diḿeny, M. Kaijser, E. Larsson, A. Wanders, and J. Wahlberg. 1996. Nonimmunological factors involved in long-term allograft deterioration. Adv. Nephrol. Necker Hosp. 25:51-62.
34. Rubin, K., A. Tingström, G.K. Hansson, E. Larsson, L. Rönnstrand, L. Klareskog, L. Claesson-Welsh, C.-H. Heldin, and B. Fellström. 1988. Induction of B-type receptors for platelet-derived growth factor in vascular inflammation: possible implication for development of vascular proliferative lesions. Lancet. 1:1099-1102.
35. Paul, L.C. 1995. Chronic renal transplant loss. Kidney Int. 36:1491-1499.
36. Waltenberger, J., M.L. Akyürek, M. Aurivillius, A. Wanders, E. Larsson, B.C. Fellström, and K. Funa. 1996. Ischemia-induced transplant arteriosclerosis in the rat. Induction of peptide growth factor expression. Arterioscler. Thromb. Vasc. Biol. 16:1516-1523.
37. Fukuo, K., S. Hata, T. Suhara, T. Nakahashi, Y. Shinto, Y. Tsujimoto, S. Morimoto, and T. Ogihara. 1996. Nitric oxide induces upregulation of Fas and apoptosis in vascular smooth muscle. Hypertension. 27:823-826.
38. Geng, Y.-G., L.E. Henderson, E.B. Levesque, M. Muszynski, and P. Libby. 1997. Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 17:2200-2208.
39. Bochaton-Piallat, M., P. Ropraz, F. Gabbiani, and G. Gabbiani. 1996. Phenotypic heterogeneity of rat arterial smooth muscle cell clones. Implications for the development of experimental intimal thickening. Arterioscler. Thromb. Vasc. Biol. 16:815-820.
40. Perlman, H., L. Maillard, K. Krasinski, and K. Walsh. 1997. Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury. Circulation. 95:981-987.
41. Mennander, A., S. Tiisala, J. Halttunen, S. Yilmaz, T. Paavonen, and P. Häyry. 1991. Chronic rejection in rat aortic allografts. An experimental model for transplant arteriosclerosis. Arterioscler. Thromb. 11:671-680.
42. Leszczynski, D., Y. Zhao, M. Luokkamäki, and M.L. Foegh. 1994. Apoptosis of vascular smooth muscle cells. Protein kinase C and oncoprotein Bcl-2 are involved in regulation of apoptosis in nontransformed rat vascular smooth muscle cells. Am. J. Pathol. 145:1265-1270.
43. Geng, Y.-G., Q. Wu, M. Muszynski, G.K. Hansson, and P. Libby. 1996. Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-γ, tumor necrosis factor-α, and interleukin-1β. Arterioscler. Thromb. Vasc. Biol. 16:19-27.
44. Bennett, M.R., G.I. Evan, and S.M. Schwartz. 1995. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J. Clin. Invest. 95:2266-2274.
45. Lantz, I., E. Dimény, E. Larsson, B. Fellstrom, and K. Funa. 1996. Increased immunoreactivity of transforming growth factor-β in kidney transplants. Transplant. Immunol. 4:209-214.
46. Akyürek, L.M., B.C. Fellström, Z.Q. Yan, G.K. Hansson, K. Funa, and E. Larsson. 1996. Inducible and endothelial nitric oxide synthase expression during development of transplant arteriosclerosis. Am. J. Pathol. 149:1981-1990.
47. Nabel, E.G., L. Shum, V.J. Pompili, Z.Y. Yang, H. San, H.B. Shu, S. Liptay, L. Gold, D. Gordon, R. Derynck, et al. 1993. Direct transfer of transforming growth factor β1 gene into arteries stimulates fibrocellular hyperplasia. Proc. Natl. Acad. Sci. USA. 90:10759-10763.
48. Shears, L.L., N. Kawaharada, E. Tzeng, T.R. Billiar, S.C. Watkins, I. Kovesdi, A. Lizonova, and S.M. Pham. 1997. Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis. J. Clin. Invest. 100: 2035-2042.
49. Nishio, E., K. Fukushima, M. Shiozaki, and Y. Watanabe. 1996. Nitric oxide donor SNAP induces apoptosis in smooth muscle cells through cGMP-independent mechanism. Biochem. Biophys. Res. Commun. 221:163-168.
50. Tsukada, T., K. Eguchi, K. Migita, Y. Kawabe, A. Kawakami, N. Matsuoka, H. Takashima, A. Mizokami, and S. Nagataki. 1995. Transforming growth factor β1 induces apoptotic cell death in cultured human umbilical vein endothelial cells with down-regulated expression of bcl-2. Biochem. Biophys. Res. Commun. 210:1076-1082.
51. Yang, X., N.F. Galeano, M. Szabolcs, R.R. Sciacca, and P.J. Cannon. 1996. Oxidized low density lipoproteins alter macrophage lipid uptake, apoptosis, viability, and nitric oxide synthesis. J. Nutr. 126(Suppl.):1072S-1075S.
52. Kiener, P.A., P.M. Davis, G.C. Starling, C. Mehlin, S.J. Klebanoff, J.A. Ledbetter, and W.C. Liles. 1997. Differential induction of apoptosis by Fas-Fas ligand interactions in human monocytes and macrophages. J. Exp Med 185:1511-1516.
53. Mitchinson, M.J., S.J. Hardwick, and M.R. Bennett. 1996. Cell death in atherosclerotic plaques. Curr. Opin. Lipidol. 7:324-329.